Enzo潜在的癌症治疗靶点-去泛素化酶(DUBs)
自从蛋白酶体抑制剂硼替佐米(bortezomib, Velcade))批准用于治疗多发性骨髓瘤后,作为治疗癌症的新方法——泛素蛋白酶体途径备受关注。在信号通道中去泛素化酶(DUBs)是一种特殊的“可用药物靶点”,许多科研人员开发其抑制剂作为潜在的抗癌药物。西班牙巴塞罗那瓦尔德希伯伦肿瘤研究所Dr. Joan Seoane和许多学者都证实DUB——泛素特异性肽酶15(USP15),在恶性胶质瘤和其它恶性肿瘤中对转化生长因子β(TGF-β)起重要调节作用(Eichhorn et al (2012) Nat Med, doi: 10.1038/nm.2619)。TGF-β是中晚期肿瘤的致癌因子,促使TGF-β受体I型和II型(TβR-I和TβR-II)形成异质二聚体复合物,最终激活信号级联反应。这种信号途径可由泛素化来调节,而USP15会抑制泛素化。在胶质瘤的小鼠模型中通过抑制USP15,可降低TGF-β活性,减少肿瘤生长。从人类肿瘤疾病模型中可以看出,USP15基因大量扩增,不利于患者的诊断治疗。
Enzo Life Sciences可提供全面的产品,用于检测DUBs在药物治疗上起何种关键性调控作用。
Product
|
Highlight
|
USP15 (human), (recombinant) (His-tag)
|
>95% purity by SDS-PAGE
|
USP15 (human), pAb
|
Recognizes human and mouse USP15.
|
Deubiquitinylating enzyme probes, sampler pack
|
Active site-directed probes for detection of DUBs
|
Ubiquitin aldehyde, (recombinant)
|
High purity inhibitor of deubiquitinylating enzymes (DUBs).
|
Ubiquitin-AMC
|
Fluorogenic substrate for a wide range of DUBs
|
Ubiquitin vinyl sulfone, (HA-tag)
|
Potent and irreversible inhibitor of DUBs
|
Ubiquitin vinyl methyl ester, HA-tagged
|
Active site-directed probe for detection of DUBs.
|
Chloroethyl-ubiquitin, HA-tagged
|
Active site-directed probe for detection of DUBs.
|
Bromoethyl-ubiquitin, HA-tagged
|
Active site-directed probe for detection of DUBs.
|
TGF-β1 ELISA kit
|
Reliably measures as little as 3.3 pg/ml
|
TGF-β1 (human platelets)
|
>95% purity by SDS-PAGE
|
ALK5 Inhibitor I
|
Cell permeable, potent, selective and ATP-competitive inhibitor of TGF-β RI kinase (IC50=51nM).
|